Cutaneous eruptions and in vitro lymphocyte hypersensitivity. Associated with oral contraceptives and mestranol.
D000328:Adult; D003276:Contraceptives, Oral / Q000009:adverse effects*; D004342:Drug Hypersensitivity; D004892:Erythema Multiforme / Q000139:chemically induced* / Q000276:immunology; D004893:Erythema Nodosum / Q000139:chemically induced* / Q000276:immunology; D004967:Estrogens / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology*; D008656:Mestranol / Q000009:adverse effects* / Q000494:pharmacology
D003276:Contraceptives, Oral; D004967:Estrogens; D008656:Mestranol